Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_49490 | 48 | 1.00 | Mlig455_054769 | Neo: - Age: - |
Mlig455_054769 {REF} {Length: 1663} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -5.492 | 1.221 | 1.00000 | 1.00000 | |
RegionR2 | 6.13 | 1.221 | 0.01850 | 0.14564 | |
RegionR3 | 1.133 | 1.221 | 0.99984 | 1.00000 | |
RegionR4 | 0.273 | 1.221 | 0.35232 | 0.67427 | |
RegionR5 | 0.762 | 1.221 | 1.00000 | 1.00000 | |
RegionR6 | 0.619 | 1.221 | 1.00000 | 1.00000 | |
RegionR7 | -0.425 | 1.221 | 0.99997 | 1.00000 | |
RegionR8 | -2.999 | 1.221 | 0.99991 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 1.141 | 1.221 | 0.99994 | 1.00000 | |
RegenerationR2 | 1.543 | 1.221 | 0.33671 | 0.77243 | |
RegenerationR3 | 1.887 | 1.221 | 0.27817 | 0.71151 | |
RegenerationR4 | 0.297 | 1.221 | 0.71055 | 0.95755 | |
RegenerationR5 | -0.496 | 1.221 | 1.00000 | 1.00000 | |
RegenerationR6 | -0.497 | 1.221 | 1.00000 | 1.00000 | |
RegenerationBL | 4.425 | 1.221 | 0.04235 | 0.23429 | |
RegenerationTP | 3.483 | 1.221 | 0.17908 | 0.61458 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_49490 | 48 | 1 | Mlig455_054769 | Neo: - Age: - |
4 | - | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_054769 {REF} {Length: 1663} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
2. | MligTC455_37792 | 210 | 4.38 | Mlig455_024774 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.926 Region-enriched R2: 6.055/0.00271 |
PKD1L2 | 3.731 | - | - | 0.958 | 0.943 | 0.988 | 0.842 | Mlig455_024774 {REF} {Length: 6374} {Pfam: Polycystin cation channel [PF08016.14, score=224.6]; PLAT/LH2 domain [PF01477.25, score=66.8]; Ion transport protein [PF00520.33, score=30.8]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=179, Expect=9e-45]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=187, Expect=3e-47]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=109, Expect=1e-23]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=187, Expect=2e-47]} {Smed: dd_Smed_v6_13975_0_1, dd_Smed_v6_13975_0_1, [Score=902, Expect=0.0]} {RNA1509_46134} {RNA1310_488} {RNA815_1711} |
3. | MligTC455_32312 | 65 | 1.36 | Mlig455_026936, Mlig455_027086 | Neo: - Age: Up-Down-Down Region-enriched R2: 9.552/0.00000 |
3.73 | - | - | 0.982 | 0.860 | 0.911 | 0.977 | Mlig455_026936 {REF} {Length: 1813} {Pfam: PAN domain [PF00024.28, score=22.0]} {RNA1310_30037.2} {RNA815_37290} Mlig455_027086 {REF} {Length: 7697} {Pfam: PAN domain [PF00024.28, score=21.9]} {RNA1509_4722} {RNA1310_655.1} {RNA815_786} |
|
4. | MligTC455_38010 | 38 | 0.79 | Mlig455_059485 | Neo: - Age: - |
3.728 | - | - | 0.852 | 0.933 | 0.971 | 0.972 | Mlig455_059485 {REF} {Length: 1213} {Pfam: Lectin C-type domain [PF00059.23, score=24.8]} {RNA1509_20946} {RNA1310_35102} {RNA815_16139} | |
5. | MligTC455_46708 | 362 | 7.53 | Mlig455_045334 | Neo: - Age: - Region-enriched R2: 2.783/0.01800 |
3.706 | - | - | 0.957 | 0.957 | 0.965 | 0.827 | Mlig455_045334 {REF} {Length: 1243} {RNA1509_51601} {RNA1310_43115.2, RNA1509_51601} {RNA1509_51601, RNA815_21402.1} | |
6. | MligTC455_48634 | 30 | 0.62 | Mlig455_006052, Mlig455_068060 | Neo: - Age: - |
ANGPTL4, FCN2 | 3.684 | - | - | 0.995 | 0.931 | 0.988 | 0.770 | Mlig455_006052 {REF} {Length: 2091} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=64.0]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=83.6, Expect=2e-17]} {Mouse: ENSMUSG00000042436, Mfap4, microfibrillar-associated protein 4, [Score=71.6, Expect=9e-14]} {Dmel: FBgn0034160, CG5550, [Score=67.4, Expect=2e-12]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=62.0, Expect=2e-10]} {RNA1310_118683} Mlig455_068060 {REF} {Length: 1573} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.6]} {Human: ENSG00000167772, ANGPTL4, angiopoietin like 4, [Score=53.9, Expect=9e-08]} {Mouse: ENSMUSG00000028553, Angptl3, angiopoietin-like 3, [Score=50.4, Expect=9e-07]} {Dmel: FBgn0050280, CG30280, [Score=57.0, Expect=2e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=53.9, Expect=3e-08]} {RNA1310_87835} |
7. | MligTC455_26255 | 126 | 2.63 | Mlig455_053706 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.424/0.00107 |
FZD5 | 3.654 | - | - | 0.991 | 0.915 | 0.985 | 0.763 | Mlig455_053706 {REF} {Length: 3671} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=393.1]; Fz domain [PF01392.24, score=105.2]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [RH, Score=607, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=600, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [RH, Score=562, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [RH, Score=412, Expect=5e-137]} {Smed: dd_Smed_v6_11823_0_1, dd_Smed_v6_11823_0_1, [RH, Score=551, Expect=0.0]} {RNA1509_49831} {RNA1310_28187, RNA1509_49831} {RNA1509_49831, RNA815_16996} |
8. | MligTC455_13171 | 25 | 0.53 | Mlig455_005963, Mlig455_005967 | Neo: - Age: - |
3.647 | - | - | 0.926 | 0.968 | 0.988 | 0.765 | Mlig455_005963 {REF} {Length: 2617} {RNA1509_20946} {RNA1310_146331} {RNA815_35450} Mlig455_005967 {REF} {Length: 1405} {Pfam: Lectin C-type domain [PF00059.23, score=20.7]} {RNA1509_20946} {RNA1310_146331} {RNA815_35450} |
|
9. | MligTC455_17464 | 409 | 8.52 | Mlig455_048989, Mlig455_049006, Mlig455_067762 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.512 Regeneration-downregulated BL: -7.800 Regeneration-depleted BL: -7.800 |
3.646 | - | - | 0.973 | 0.992 | 0.928 | 0.753 | Mlig455_048989 {REF} {Length: 1272} {RNA1310_37715} {RNA815_39767} Mlig455_049006 {REF} {Length: 1028} {RNA1310_37715} {RNA815_39767} Mlig455_067762 {REF} {Length: 1353} {RNA1310_37715} {RNA815_39767} |
|
10. | MligTC455_18683 | 419 | 8.74 | Mlig455_069928 | Neo: - Age: - Region-specific R2: 6.066 Region-enriched R2: 4.921/0.00217 |
3.637 | - | - | 0.944 | 0.951 | 0.975 | 0.767 | Mlig455_069928 {REF} {Length: 845} {RNA1509_25826} {RNA1310_42757} {RNA815_23874} | |
11. | MligTC455_39096 | 110 | 2.29 | Mlig455_019781, Mlig455_019803 | Neo: - Age: - |
3.636 | - | - | 0.937 | 0.945 | 0.983 | 0.771 | Mlig455_019781 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=65.0]} {RNA1310_34740} {RNA815_15663} Mlig455_019803 {REF} {Length: 1107} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.1]} {RNA1310_34740} {RNA815_15663} |
|
12. | MligTC455_39481 | 461 | 9.6 | Mlig455_056703, Mlig455_060318 | Neo: - Age: Down-Up-Up Region-specific R2: 4.222 |
ANGPTL1 | 3.635 | - | - | 0.943 | 0.977 | 0.900 | 0.815 | Mlig455_056703 {REF} {Length: 1114} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=79.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=89.4, Expect=1e-19]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=85.1, Expect=3e-18]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=91.3, Expect=2e-20]} {Dmel: FBgn0033312, CG8642, [Score=82.4, Expect=1e-17]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=76.3, Expect=1e-15]} {RNA1310_31288} {RNA815_20497.1} Mlig455_060318 {REF} {Length: 1175} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=112.7]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=106, Expect=2e-25]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=6e-26]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=109, Expect=1e-26]} {Dmel: FBgn0034160, CG5550, [Score=96.3, Expect=2e-23]} {Celegans: WBGene00016769, C49C8.5, [Score=47.0, Expect=9e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=88.2, Expect=2e-19]} {RNA1310_31288} {RNA815_20497.1} |
13. | MligTC455_14903 | 1751 | 36.49 | Mlig455_037514 | Neo: - Age: - Region-enriched R8: 1.893/0.00470 |
3.624 | - | - | 0.928 | 0.925 | 0.953 | 0.818 | Mlig455_037514 {REF} {Length: 2886} {Dmel: FBgn0034294, Muc55B, Mucin 55B, [Score=58.5, Expect=6e-09]} {Celegans: WBGene00008194, C49C3.4, [Score=51.2, Expect=1e-06]} {RNA1509_4337} {RNA1310_7259} {RNA815_206} | |
14. | MligTC455_40852 | 128 | 2.66 | Mlig455_042301 | Neo: - Age: Up-Up-Down, logFC(26M/2M)=0.671 Region-enriched R2: 6.158/0.00357 |
PKDREJ | 3.622 | - | - | 0.954 | 0.801 | 0.979 | 0.888 | Mlig455_042301 {REF} {Length: 11184} {Pfam: Polycystin cation channel [PF08016.14, score=273.5]; PKD domain [PF00801.22, score=86.2]; PLAT/LH2 domain [PF01477.25, score=67.1]; REJ domain [PF02010.17, score=66.8]; PKD domain [PF18911.2, score=62.3]; Ion transport protein [PF00520.33, score=45.4]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=283, Expect=2e-75]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=273, Expect=2e-72]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=158, Expect=3e-38]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=254, Expect=4e-67]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=514, Expect=2e-146]} {RNA1509_8046} {RNA1310_93, RNA1509_8046} {RNA1509_8046, RNA815_1216} |
15. | MligTC455_15450 | 19 | 0.39 | Mlig455_006618 | Neo: - Age: - |
3.62 | - | - | 0.944 | 0.942 | 0.963 | 0.771 | Mlig455_006618 {REF} {Length: 653} {Pfam: WSC domain [PF01822.21, score=30.6]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.5, Expect=7e-09]} {RNA1310_35396.1} {RNA815_56551} | |
16. | MligTC455_39890 | 162 | 3.37 | Mlig455_047281, Mlig455_047331, Mlig455_069333 | Neo: - Age: - Region-enriched R2: 6.097/0.00148 |
PLSCR1 | 3.615 | - | - | 0.943 | 0.933 | 0.977 | 0.762 | Mlig455_047281 {REF} {Length: 1404} {Pfam: Scramblase [PF03803.17, score=248.1]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=225, Expect=4e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=227, Expect=5e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=222, Expect=3e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=223, Expect=6e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=2e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=306, Expect=1e-104]} {RNA1310_29769} {RNA815_41335} Mlig455_047331 {REF} {Length: 1395} {Pfam: Scramblase [PF03803.17, score=248.1]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=225, Expect=4e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=227, Expect=5e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=222, Expect=3e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=223, Expect=6e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=2e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=306, Expect=1e-104]} {RNA1310_29769} {RNA815_41335} Mlig455_069333 {REF} {Length: 1416} {Pfam: Scramblase [PF03803.17, score=248.7]} {Human: ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=226, Expect=1e-72]} {Mouse: ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=228, Expect=2e-73]; ENSMUSG00000032372, Plscr2, phospholipid scramblase 2, [Score=223, Expect=1e-71]} {Dmel: FBgn0052056, scramb1, scramblase 1, [Score=224, Expect=2e-73]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=194, Expect=4e-61]} {Smed: dd_Smed_v6_16813_0_1, dd_Smed_v6_16813_0_1, [RH, Score=304, Expect=2e-103]} {RNA1310_29769} {RNA815_41335} |
17. | MligTC455_43581 | 177 | 3.68 | Mlig455_042725, Mlig455_042827, Mlig455_063146 | Neo: - Age: Up-Down-Down |
GRIA2 | 3.613 | - | - | 0.938 | 0.951 | 0.994 | 0.730 | Mlig455_042725 {REF} {Length: 3074} {Pfam: Ligand-gated ion channel [PF00060.28, score=104.7]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.7]; Receptor family ligand binding region [PF01094.30, score=33.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=19.7]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=153, Expect=1e-37]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=149, Expect=2e-36]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=147, Expect=7e-36]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=152, Expect=2e-37]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=148, Expect=3e-36]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=147, Expect=8e-36]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=145, Expect=2e-35]} {Dmel: FBgn0038837, CG3822, [Score=140, Expect=5e-34]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=126, Expect=1e-29]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=253, Expect=2e-76]} {RNA1310_25150} {RNA815_13942} Mlig455_042827 {REF} {Length: 2869} {Pfam: Ligand-gated ion channel [PF00060.28, score=83.9]; Receptor family ligand binding region [PF01094.30, score=49.8]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=44.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.3]; Iron-containing alcohol dehydrogenase [PF13685.8, score=18.6]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=125, Expect=6e-29]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=122, Expect=5e-28]; ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=121, Expect=7e-28]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=120, Expect=2e-27]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=125, Expect=5e-29]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=122, Expect=4e-28]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=121, Expect=1e-27]; ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=120, Expect=1e-27]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=119, Expect=3e-27]} {Dmel: FBgn0039927, CG11155, [Score=127, Expect=7e-30]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=103, Expect=1e-22]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=217, Expect=2e-63]} {RNA1310_25150} {RNA815_13942} Mlig455_063146 {REF} {Length: 2444} {Pfam: Receptor family ligand binding region [PF01094.30, score=35.8]} {Smed: dd_Smed_v6_31078_0_1, dd_Smed_v6_31078_0_1, [Score=82.4, Expect=1e-16]} {RNA1310_25150} {RNA815_13999} |
18. | MligTC455_47905 | 56 | 1.16 | Mlig455_037694 | Neo: - Age: - |
3.613 | - | - | 0.931 | 0.960 | 0.970 | 0.752 | Mlig455_037694 {REF} {Length: 2503} {RNA1310_36768.1} {RNA815_27683} | |
19. | MligTC455_45495 | 988 | 20.58 | Mlig455_010003 | Neo: - Age: logFC(26M/2M)=0.384 Region-enriched R2: 2.517/0.00003 |
CAV2 | 3.611 | - | - | 0.892 | 0.936 | 0.984 | 0.799 | Mlig455_010003 {REF} {Length: 748} {Pfam: Caveolin [PF01146.19, score=125.0]} {Human: ENSG00000105971, CAV2, caveolin 2, [Score=85.5, Expect=3e-21]} {Mouse: ENSMUSG00000000058, Cav2, caveolin 2, [Score=89.4, Expect=7e-23]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=79.0, Expect=2e-18]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [RH, Score=153, Expect=1e-48]} {RNA1509_20287} {RNA1310_50581.1} {RNA815_31873} |
20. | MligTC455_19042 | 3679 | 76.64 | Mlig455_030661 | Neo: - Age: logFC(26M/2M)=0.480 Region-specific R2: 2.811 Region-enriched R2: 1.755/0.00003 |
CAV1 | 3.608 | - | - | 0.934 | 0.957 | 0.987 | 0.730 | Mlig455_030661 {REF} {Length: 1257} {Pfam: Caveolin [PF01146.19, score=124.8]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=105, Expect=2e-29]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=105, Expect=2e-29]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [RH, Score=81.6, Expect=8e-20]} {Smed: dd_Smed_v6_13481_0_1, dd_Smed_v6_13481_0_1, [RH, Score=144, Expect=1e-45]} {RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522} {RNA1310_31540, RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522} {RNA1509_52150, RNA1509_53381, RNA1509_6093, RNA1509_8522, RNA815_14585} |
21. | MligTC455_16201 | 175 | 3.64 | Mlig455_041123, Mlig455_041179 | Neo: - Age: Down-Up-Up |
3.608 | - | - | 0.900 | 0.848 | 0.955 | 0.905 | Mlig455_041123 {REF} {Length: 2988} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=40.5]} {Smed: dd_Smed_v6_4798_0_1, dd_Smed_v6_4798_0_1, [RH, Score=74.7, Expect=7e-16]} {RNA1509_42904} {RNA1310_20004} {RNA815_27472.1} Mlig455_041179 {REF} {Length: 2106} {Pfam: Fas apoptotic inhibitory molecule (FAIM1) [PF06905.15, score=40.5]} {Smed: dd_Smed_v6_4798_0_1, dd_Smed_v6_4798_0_1, [RH, Score=74.7, Expect=7e-16]} {RNA1509_54374} {RNA1310_48801} {RNA815_35149} |
|
22. | MligTC455_34498 | 36 | 0.75 | Mlig455_029862 | Neo: - Age: - |
NPLOC4 | 3.603 | - | - | 0.959 | 0.930 | 0.949 | 0.765 | Mlig455_029862 {REF} {Length: 1491} {TRANSSPLICED} {Pfam: NPL4 family, putative zinc binding region [PF05020.17, score=77.9]} {Human: ENSG00000182446, NPLOC4, NPL4 homolog, ubiquitin recognition factor, [Score=98.2, Expect=1e-21]} {Mouse: ENSMUSG00000039703, Nploc4, NPL4 homolog, ubiquitin recognition factor, [Score=102, Expect=3e-23]} {Celegans: WBGene00019121, npl-4.2, NPL (Yeast Nuclear Protein Localization) homolog, [Score=54.3, Expect=6e-08]} {Smed: dd_Smed_v6_5277_0_1, dd_Smed_v6_5277_0_1, [Score=102, Expect=1e-23]} {RNA1509_6797} {RNA1310_13992} {RNA815_5567} |
23. | MligTC455_11229 | 51 | 1.06 | Mlig455_054212 | Neo: - Age: - |
3.602 | - | - | 0.945 | 0.910 | 0.979 | 0.768 | Mlig455_054212 {REF} {Length: 1481} {RNA1310_23944} {RNA815_32018} | |
24. | MligTC455_41540 | 190 | 3.96 | Mlig455_060056 | Neo: - Age: - Region-enriched R2: 6.605/0.00196 |
GLUL | 3.602 | - | - | 0.963 | 0.926 | 0.942 | 0.771 | Mlig455_060056 {REF} {Length: 1355} {Pfam: Glutamine synthetase, catalytic domain [PF00120.26, score=57.3]; Glutamine synthetase, beta-Grasp domain [PF03951.21, score=47.5]} {Human: ENSG00000135821, GLUL, glutamate-ammonia ligase, [RH, Score=511, Expect=1e-180]} {Mouse: ENSMUSG00000026473, Glul, glutamate-ammonia ligase (glutamine synthetase), [RH, Score=511, Expect=0.0]} {Dmel: FBgn0001145, Gs2, Glutamine synthetase 2, [RH, Score=511, Expect=0.0]} {Celegans: WBGene00001604, gln-3, Glutamine synthetase, [RH, Score=515, Expect=0.0]} {Smed: dd_Smed_v6_896_0_1, dd_Smed_v6_896_0_1, [RH, Score=545, Expect=0.0]} {RNA1509_47000} {RNA1310_22329.2} {RNA815_4116.6} |
25. | MligTC455_49491 | 136 | 2.83 | Mlig455_054796 | Neo: - Age: - Region-enriched R2: 7.065/0.00003 |
3.602 | - | - | 0.985 | 0.886 | 0.961 | 0.770 | Mlig455_054796 {REF} {Length: 1567} {RNA1509_22234} {RNA1310_23973} {RNA815_10832} | |
26. | MligTC455_18506 | 59 | 1.23 | Mlig455_038054 | Neo: - Age: Down-Up-Down |
SP9 | 3.6 | - | - | 0.979 | 0.959 | 0.906 | 0.756 | Mlig455_038054 {REF} {Length: 3168} {Pfam: Zinc-finger double domain [PF13465.8, score=49.0]; Zinc finger, C2H2 type [PF00096.28, score=40.9]; C2H2-type zinc finger [PF13894.8, score=26.8]} {Human: ENSG00000217236, SP9, Sp9 transcription factor, [RH, Score=202, Expect=4e-59]; ENSG00000164651, SP8, Sp8 transcription factor, [RH, Score=202, Expect=5e-59]} {Mouse: ENSMUSG00000068859, Sp9, trans-acting transcription factor 9, [RH, Score=202, Expect=3e-59]; ENSMUSG00000048562, Sp8, trans-acting transcription factor 8, [RH, Score=201, Expect=9e-59]} {Dmel: FBgn0020378, Sp1, [RH, Score=198, Expect=6e-56]} {Celegans: WBGene00012735, sptf-3, SP (Specificity Protein) Transcription Factor, [Score=137, Expect=1e-35]} {Smed: dd_Smed_v6_17385_0_1, dd_Smed_v6_17385_0_1, [RH, Score=160, Expect=5e-46]} {RNA1310_42373} |
27. | MligTC455_40989 | 801 | 16.68 | Mlig455_016294 | Neo: - Age: logFC(26M/2M)=0.270 |
PKD2 | 3.599 | - | - | 0.940 | 0.960 | 0.942 | 0.757 | Mlig455_016294 {REF} {Length: 3179} {Pfam: Polycystin cation channel [PF08016.14, score=486.5]; Ion transport protein [PF00520.33, score=90.3]; EF hand [PF00036.34, score=23.7]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=718, Expect=0.0]; ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [RH, Score=712, Expect=0.0]} {Mouse: ENSMUSG00000037578, Pkd2l1, polycystic kidney disease 2-like 1, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=310, Expect=2e-91]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=370, Expect=7e-116]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=743, Expect=0.0]} {RNA1509_14023, RNA1509_24240} {RNA1310_4836.1, RNA1509_14023, RNA1509_24240} {RNA1509_14023, RNA1509_24240, RNA815_4677} |
28. | MligTC455_51537 | 225 | 4.69 | Mlig455_064569 | Neo: - Age: - |
3.595 | - | - | 0.967 | 0.927 | 0.802 | 0.899 | Mlig455_064569 {REF} {Length: 2141} {RNA1310_34295.1} {RNA815_22630} | |
29. | MligTC455_14904 | 4225 | 88.01 | Mlig455_037596 | Neo: - Age: logFC(26M/2M)=0.385 Region-enriched R8: 1.541/0.00053 |
3.595 | - | - | 0.922 | 0.954 | 0.957 | 0.762 | Mlig455_037596 {REF} {Length: 2914} {Dmel: FBgn0034294, Muc55B, Mucin 55B, [Score=59.3, Expect=3e-09]} {RNA1509_17730, RNA1509_4337} {RNA1310_7259, RNA1509_17730} {RNA1509_17730, RNA815_206} | |
30. | MligTC455_04786 | 26 | 0.55 | Mlig455_043817, Mlig455_047431 | Neo: - Age: - |
3.587 | - | - | 0.935 | 0.907 | 0.981 | 0.764 | Mlig455_043817 {REF} {Length: 319} {NoTransDecoderORF} {RNA1310_64690} Mlig455_047431 {REF} {Length: 2194} {Pfam: Glycine rich protein [PF12810.9, score=25.3]} {RNA1509_16377} {RNA1310_33363.2} {RNA815_25152} |
|
31. | MligTC455_52232 | 92 | 1.92 | Mlig455_007894, Mlig455_008001 | Neo: - Age: logFC(26M/2M)=0.549 |
3.587 | - | - | 0.907 | 0.926 | 0.986 | 0.768 | Mlig455_007894 {REF} {Length: 1500} {RNA1310_22136} {RNA815_18832} Mlig455_008001 {REF} {Length: 1450} {Pfam: PAN domain [PF00024.28, score=18.9]} {RNA1310_22136} {RNA815_18832} |
|
32. | MligTC455_47875 | 72 | 1.5 | Mlig455_067941 | Neo: - Age: - |
3.579 | - | - | 0.934 | 0.983 | 0.951 | 0.711 | Mlig455_067941 {REF} {Length: 1399} {Smed: dd_Smed_v6_3944_0_1, dd_Smed_v6_3944_0_1, [Score=97.8, Expect=7e-26]} {RNA1509_55952} {RNA1310_12426} {RNA815_33214} | |
33. | MligTC455_34499 | 65 | 1.36 | Mlig455_025160, Mlig455_063937 | Neo: - Age: - |
3.572 | - | - | 0.957 | 0.900 | 0.947 | 0.768 | Mlig455_025160 {REF} {Length: 942} {RNA1310_54940} {RNA815_33690.1} Mlig455_063937 {REF} {Length: 995} {RNA1310_54940} {RNA815_33690.1} |
|
34. | MligTC455_44646 | 193 | 4.01 | Mlig455_013515 | Neo: - Age: Down-Up-Down |
SCNN1B | 3.564 | - | - | 0.929 | 0.944 | 0.989 | 0.702 | Mlig455_013515 {REF} {Length: 2272} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=308.7]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [RH, Score=191, Expect=3e-52]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [RH, Score=188, Expect=3e-51]} {Dmel: FBgn0030795, ppk28, pickpocket 28, [Score=68.2, Expect=1e-11]} {Celegans: WBGene00012137, asic-2, Degenerin-like protein asic-2, [Score=143, Expect=2e-36]} {Smed: dd_Smed_v6_17021_0_1, dd_Smed_v6_17021_0_1, [Score=175, Expect=2e-47]} {RNA1509_52917} {RNA1310_12013.1, RNA1509_52917} {RNA1509_52917, RNA815_4777} |
35. | MligTC455_15679 | 88 | 1.82 | Mlig455_057219 | Neo: - Age: Down-Up-Up |
WSCD2 | 3.56 | - | - | 0.917 | 0.891 | 0.982 | 0.770 | Mlig455_057219 {REF} {Length: 1035} {Pfam: WSC domain [PF01822.21, score=55.1]; PAN domain [PF00024.28, score=27.0]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.8, Expect=2e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=51.6, Expect=3e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.5, Expect=5e-08]} {RNA1509_46267} {RNA1310_46146} {RNA815_32275.1} |
36. | MligTC455_33040 | 203 | 4.23 | Mlig455_032497 | Neo: - Age: logFC(26M/2M)=0.515 Region-enriched R2: 4.005/0.00408 |
PKD2L1 | 3.557 | - | - | 0.978 | 0.916 | 0.925 | 0.738 | Mlig455_032497 {REF} {Length: 3318} {Pfam: Polycystin cation channel [PF08016.14, score=293.1]; Ion transport protein [PF00520.33, score=39.7]} {Human: ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=236, Expect=4e-66]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=261, Expect=3e-73]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=131, Expect=5e-31]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=180, Expect=1e-47]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=641, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
37. | MligTC455_45039 | 168 | 3.49 | Mlig455_040482, Mlig455_040487 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.332/0.02336 |
3.555 | - | - | 0.963 | 0.857 | 0.970 | 0.765 | Mlig455_040482 {REF} {Length: 1774} {RNA1310_20941} {RNA815_45079} Mlig455_040487 {REF} {Length: 5763} {tRNA: Val(CAC),pseudo, score=20.2} {Celegans: WBGene00022195, Y71H2B.5, [Score=146, Expect=8e-36]} {Smed: dd_Smed_v6_16438_0_2, dd_Smed_v6_16438_0_2, [Score=188, Expect=1e-49]} {RNA1509_21228} {RNA1310_20941} {RNA815_45079} |
|
38. | MligTC455_13130 | 40 | 0.83 | Mlig455_032511, Mlig455_068691 | Neo: - Age: - |
WSCD2 | 3.541 | - | - | 0.992 | 0.881 | 0.946 | 0.722 | Mlig455_032511 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=40.9]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.4, Expect=6e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {RNA1310_39527} {RNA815_19067} Mlig455_068691 {REF} {Length: 927} {Pfam: WSC domain [PF01822.21, score=41.8]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.1, Expect=1e-06]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=49.7, Expect=9e-07]; ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=47.8, Expect=4e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=62.0, Expect=6e-11]} {RNA1310_39527} {RNA815_19067} |
39. | MligTC455_44176 | 89 | 1.85 | Mlig455_022911 | Neo: - Age: - |
TNKS | 3.54 | - | - | 0.951 | 0.956 | 0.923 | 0.710 | Mlig455_022911 {REF} {Length: 1883} {Pfam: Ankyrin repeats (many copies) [PF13637.8, score=67.0]; Ankyrin repeats (3 copies) [PF12796.9, score=64.6]; Ankyrin repeats (many copies) [PF13857.8, score=59.2]; Ankyrin repeat [PF13606.8, score=50.9]; Ankyrin repeat [PF00023.32, score=50.1]} {Human: ENSG00000173273, TNKS, tankyrase, [Score=57.8, Expect=3e-08]; ENSG00000285372, AC270292.3, tankyrase, [Score=56.6, Expect=7e-08]; ENSG00000236759, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000238134, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000204371, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000206376, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000227333, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000232045, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.8, Expect=1e-07]; ENSG00000224143, EHMT2, euchromatic histone lysine methyltransferase 2, [Score=55.5, Expect=2e-07]; ENSG00000029534, ANK1, ankyrin 1, [Score=55.5, Expect=2e-07]} {Mouse: ENSMUSG00000095294, Gm21119, predicted gene, 21119, [Score=57.8, Expect=1e-08]; ENSMUSG00000096265, 4930467E23Rik, RIKEN cDNA 4930467E23 gene, [Score=57.8, Expect=1e-08]; ENSMUSG00000031529, Tnks, tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase, [Score=57.8, Expect=2e-08]; ENSMUSG00000074449, Gm15319, predicted gene 15319, [Score=57.4, Expect=1e-08]; ENSMUSG00000013787, Ehmt2, euchromatic histone lysine N-methyltransferase 2, [Score=55.8, Expect=9e-08]; ENSMUSG00000063932, Poteg, POTE ankyrin domain family, member G, [Score=55.5, Expect=8e-08]; ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=55.5, Expect=1e-07]; ENSMUSG00000110591, Gm31371, predicted gene, 31371, [Score=55.5, Expect=4e-08]; ENSMUSG00000106824, Gm7697, predicted gene 7697, [Score=55.1, Expect=8e-08]; ENSMUSG00000107280, Gm9495, predicted gene 9495, [Score=55.1, Expect=8e-08]} {Dmel: FBgn0040752, Prosap, [Score=58.9, Expect=6e-09]} {Celegans: WBGene00001411, fem-1, Sex-determining protein fem-1, [Score=53.5, Expect=2e-07]} {Smed: dd_Smed_v6_2072_0_22, dd_Smed_v6_2072_0_22, [Score=62.0, Expect=4e-10]} {RNA1509_39040} {RNA1310_19494} {RNA815_14632} |
40. | MligTC455_09697 | 52 | 1.08 | Mlig455_009478, Mlig455_061921 | Neo: - Age: - |
CD207 | 3.524 | - | - | 0.925 | 0.878 | 0.965 | 0.756 | Mlig455_009478 {REF} {Length: 1068} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Human: ENSG00000116031, CD207, CD207 molecule, [Score=48.5, Expect=5e-06]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=68.2, Expect=1e-13]} {RNA1310_33496.1} {RNA815_23317} Mlig455_061921 {REF} {Length: 776} {Pfam: Lectin C-type domain [PF00059.23, score=35.3]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=69.7, Expect=4e-14]} {RNA1310_33496.1} {RNA815_23317} |
41. | MligTC455_18499 | 24 | 0.5 | Mlig455_012628 | Neo: - Age: - |
3.523 | - | - | 0.907 | 0.916 | 0.967 | 0.733 | Mlig455_012628 {REF} {Length: 1340} {Smed: dd_Smed_v6_500_0_1, dd_Smed_v6_500_0_1, [Score=60.5, Expect=1e-10]} {RNA1310_107419} {RNA815_46554} | |
42. | MligTC455_21755 | 70 | 1.47 | Mlig455_021213 | Neo: - Age: - |
3.522 | - | - | 0.863 | 0.976 | 0.926 | 0.757 | Mlig455_021213 {REF} {Length: 4215} {Pfam: F5/8 type C domain [PF00754.27, score=55.5]} {RNA1509_2515} {RNA1310_33166} {RNA815_14716} | |
43. | MligTC455_36014 | 1671 | 34.81 | Mlig455_004210 | Neo: - Age: Up-Up-Down Region-enriched R2: 2.167/0.00118 |
PLA2G3 | 3.517 | - | - | 0.891 | 0.886 | 0.981 | 0.759 | Mlig455_004210 {REF} {Length: 1631} {Pfam: Phospholipase A2 [PF05826.14, score=106.6]} {Human: ENSG00000100078, PLA2G3, phospholipase A2 group III, [RH, Score=97.4, Expect=6e-23]} {Mouse: ENSMUSG00000034579, Pla2g3, phospholipase A2, group III, [RH, Score=99.4, Expect=5e-24]} {Dmel: FBgn0030013, GIIIspla2, Phospholipase A2 group III, [RH, Score=97.8, Expect=5e-25]} {Smed: dd_Smed_v6_3851_0_2, dd_Smed_v6_3851_0_2, [RH, Score=103, Expect=4e-27]} {RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881} {RNA1310_22647, RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881} {RNA1509_17589, RNA1509_26075, RNA1509_28230, RNA1509_8881, RNA815_9445} |
44. | MligTC455_54338 | 49 | 1.02 | Mlig455_056485 | Neo: - Age: Up-Down-Down |
PKDREJ | 3.508 | - | - | 0.948 | 0.962 | 0.851 | 0.747 | Mlig455_056485 {REF} {Length: 11174} {Pfam: Polycystin cation channel [PF08016.14, score=290.0]; REJ domain [PF02010.17, score=90.7]; PLAT/LH2 domain [PF01477.25, score=67.3]; PKD domain [PF00801.22, score=47.7]; Ion transport protein [PF00520.33, score=40.1]; PKD domain [PF18911.2, score=29.8]; GPCR proteolysis site, GPS, motif [PF01825.23, score=27.4]; WSC domain [PF01822.21, score=27.0]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=280, Expect=1e-74]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=307, Expect=8e-83]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=151, Expect=3e-36]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=302, Expect=1e-81]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [RH, Score=1844, Expect=0.0]} {RNA1509_16432} {RNA1310_1236} {RNA815_2411} |
45. | MligTC455_19908 | 490 | 10.21 | Mlig455_047266, Mlig455_047318, Mlig455_069346 | Neo: - Age: logFC(26M/2M)=0.566 |
3.504 | - | - | 0.929 | 0.985 | 0.816 | 0.774 | Mlig455_047266 {REF} {Length: 1728} {Pfam: Glycine rich protein [PF12810.9, score=49.4]} {RNA1509_28009} {RNA1310_17226} {RNA815_32720} Mlig455_047318 {REF} {Length: 2268} {Pfam: Glycine rich protein [PF12810.9, score=36.7]} {RNA1509_28009} {RNA1310_17226, RNA1509_28009} {RNA1509_28009, RNA815_32720} Mlig455_069346 {REF} {Length: 1953} {Pfam: Glycine rich protein [PF12810.9, score=31.6]} {RNA1509_28009} {RNA1310_17226} {RNA815_32720} |
|
46. | MligTC455_31164 | 572 | 11.91 | Mlig455_029609, Mlig455_045673 | Neo: - Age: - |
3.502 | - | - | 0.930 | 0.950 | 0.799 | 0.823 | Mlig455_029609 {REF} {Length: 746} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=39.4]} {Smed: dd_Smed_v6_22533_0_1, dd_Smed_v6_22533_0_1, [Score=48.5, Expect=1e-06]} {RNA1310_96354} {RNA815_44390} Mlig455_045673 {REF} {Length: 2025} {RNA1509_21720} {RNA1310_14760} {RNA815_24583} |
|
47. | MligTC455_53682 | 393 | 8.18 | Mlig455_064952, Mlig455_066834 | Neo: - Age: Down-Up-Up Region-specific R2: 5.926 Region-enriched R2: 4.442/0.00896 |
3.489 | - | - | 0.906 | 0.999 | 0.847 | 0.737 | Mlig455_064952 {REF} {Length: 1573} {Pfam: PAN domain [PF00024.28, score=20.0]} {RNA1310_33258} {RNA815_17150} Mlig455_066834 {REF} {Length: 1573} {Pfam: PAN domain [PF00024.28, score=20.0]} {RNA1310_33258} {RNA815_17150} |
|
48. | MligTC455_47948 | 100 | 2.07 | Mlig455_005840 | Neo: - Age: - Region-enriched R2: 3.643/0.03527 |
TSPAN16 | 3.48 | - | - | 0.995 | 0.985 | 0.759 | 0.741 | Mlig455_005840 {REF} {Length: 2130} {Pfam: Tetraspanin family [PF00335.22, score=86.4]} {Human: ENSG00000130167, TSPAN16, tetraspanin 16, [Score=48.1, Expect=6e-06]} {Mouse: ENSMUSG00000025351, Cd63, CD63 antigen, [Score=50.4, Expect=7e-07]} {Dmel: FBgn0036769, Tsp74F, Tetraspanin 74F, [Score=68.2, Expect=4e-13]} {Smed: dd_Smed_v6_854_1_1, dd_Smed_v6_854_1_1, [Score=119, Expect=5e-32]} {RNA1509_35459} {RNA1310_22253, RNA1509_35459} {RNA1509_35459, RNA815_11065} |
49. | MligTC455_39988 | 83 | 1.73 | Mlig455_062081 | Neo: - Age: - |
3.478 | - | - | 0.976 | 0.873 | 0.861 | 0.768 | Mlig455_062081 {REF} {Length: 447} {NoTransDecoderORF} {RNA1509_50426} {RNA1310_88257} {RNA815_17173.4} | |
50. | MligTC455_33039 | 312 | 6.51 | Mlig455_032494 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.545/0.00267 |
PKDREJ | 3.465 | - | - | 0.970 | 0.925 | 0.843 | 0.727 | Mlig455_032494 {REF} {Length: 11952} {Pfam: Polycystin cation channel [PF08016.14, score=289.9]; REJ domain [PF02010.17, score=90.4]; PLAT/LH2 domain [PF01477.25, score=68.4]; PKD domain [PF00801.22, score=57.9]; PKD domain [PF18911.2, score=36.7]; Ion transport protein [PF00520.33, score=36.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=30.0]; WSC domain [PF01822.21, score=23.3]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=267, Expect=1e-70]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=292, Expect=3e-78]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=136, Expect=2e-31]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=297, Expect=4e-80]} {Smed: dd_Smed_v6_15525_0_1, dd_Smed_v6_15525_0_1, [Score=1504, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814} |
51. | MligTC455_26392 | 64 | 1.33 | Mlig455_001758 | Neo: - Age: - Region-enriched R4: 4.334/0.04740 |
PLD1 | 3.459 | - | - | 0.865 | 0.837 | 0.969 | 0.788 | Mlig455_001758 {REF} {Length: 4484} {Pfam: PLD-like domain [PF13091.8, score=36.1]; Phospholipase D Active site motif [PF00614.24, score=31.9]} {Human: ENSG00000075651, PLD1, phospholipase D1, [RH, Score=290, Expect=1e-86]} {Mouse: ENSMUSG00000027695, Pld1, phospholipase D1, [RH, Score=296, Expect=7e-89]} {Dmel: FBgn0033075, Pld, Phospholipase D, [RH, Score=241, Expect=1e-68]} {Celegans: WBGene00004040, pld-1, PhosphoLipase D; Phospholipase D, [RH, Score=248, Expect=9e-71]} {Smed: dd_Smed_v6_61149_0_1, dd_Smed_v6_61149_0_1, [RH, Score=247, Expect=2e-76]} {RNA1509_57028} {RNA1310_1982, RNA1509_57028} {RNA1509_57028, RNA815_17806} |
52. | MligTC455_26254 | 174 | 3.62 | Mlig455_034978 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.366 Region-enriched R2: 5.463/0.00000 Regeneration-downregulated R4: -3.454 Regeneration-depleted R4: -3.454 |
FZD5 | 3.457 | - | - | 0.990 | 0.832 | 0.886 | 0.749 | Mlig455_034978 {REF} {Length: 3353} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=393.1]; Fz domain [PF01392.24, score=105.2]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [RH, Score=607, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=600, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [RH, Score=562, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [RH, Score=412, Expect=5e-137]} {Smed: dd_Smed_v6_11823_0_1, dd_Smed_v6_11823_0_1, [RH, Score=551, Expect=0.0]} {RNA1509_49831} {RNA1310_28187} {RNA815_16996} |
53. | MligTC455_35701 | 66 | 1.37 | Mlig455_010067, Mlig455_063254, Mlig455_063279 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.716/0.02468 |
3.457 | - | - | 0.950 | 0.982 | 0.767 | 0.758 | Mlig455_010067 {REF} {Length: 2624} {Pfam: Polycystin cation channel [PF08016.14, score=46.7]} {RNA1310_62521} Mlig455_063254 {REF} {Length: 2738} {Pfam: Polycystin cation channel [PF08016.14, score=43.3]; Lipopolysaccharide assembly protein A domain [PF06305.13, score=18.4]} {RNA1509_7418} {RNA1310_62521} {RNA815_3659} Mlig455_063279 {REF} {Length: 2677} {Pfam: Polycystin cation channel [PF08016.14, score=46.0]} {RNA1310_62521} |
|
54. | MligTC455_16415 | 197 | 4.1 | Mlig455_000401 | Neo: - Age: - Region-enriched R2: 4.276/0.00982 |
ROR1 | 3.447 | - | - | 0.934 | 0.966 | 0.788 | 0.759 | Mlig455_000401 {REF} {Length: 3780} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=233.3]; Protein kinase domain [PF00069.27, score=85.9]; Immunoglobulin I-set domain [PF07679.18, score=49.4]; Immunoglobulin domain [PF13927.8, score=46.6]; Immunoglobulin domain [PF00047.27, score=31.9]; Immunoglobulin domain [PF13895.8, score=30.0]; Fz domain [PF01392.24, score=27.6]; Kringle domain [PF00051.20, score=22.3]; Immunoglobulin V-set domain [PF07686.19, score=19.5]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [RH, Score=390, Expect=1e-119]; ENSG00000169071, ROR2, receptor tyrosine kinase like orphan receptor 2, [RH, Score=379, Expect=1e-115]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [RH, Score=386, Expect=1e-118]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [RH, Score=377, Expect=4e-115]} {Dmel: FBgn0010407, Ror, [Score=286, Expect=3e-84]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=285, Expect=4e-82]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [RH, Score=439, Expect=2e-139]} {RNA1509_35395} {RNA1310_13558, RNA1509_35395} {RNA1509_35395, RNA815_27446} |
55. | MligTC455_34483 | 299 | 6.22 | Mlig455_026230, Mlig455_026246, Mlig455_052726 | Neo: - Age: - Region-enriched R4: 4.361/0.00055 |
GLRA2, GLRA3 | 3.437 | - | - | 0.799 | 0.983 | 0.706 | 0.949 | Mlig455_026230 {REF} {Length: 1814} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=127.9]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [RH, Score=344, Expect=2e-113]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [RH, Score=341, Expect=3e-112]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [RH, Score=339, Expect=1e-111]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [RH, Score=341, Expect=3e-112]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [RH, Score=339, Expect=7e-112]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [RH, Score=337, Expect=5e-111]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [RH, Score=334, Expect=1e-109]} {Dmel: FBgn0024963, GluClalpha, [RH, Score=301, Expect=6e-97]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=282, Expect=1e-88]} {Smed: dd_Smed_v6_14666_0_1, dd_Smed_v6_14666_0_1, [Score=256, Expect=4e-80]} {RNA1509_44790} {RNA1310_18963, RNA1509_44790} {RNA1509_44790, RNA815_26083} Mlig455_026246 {REF} {Length: 1934} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=76.3]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=46.8]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=176, Expect=2e-52]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=175, Expect=5e-51]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=175, Expect=7e-51]; ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=174, Expect=7e-51]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=176, Expect=1e-51]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=175, Expect=5e-52]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=175, Expect=4e-51]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=169, Expect=9e-49]} {Dmel: FBgn0024963, GluClalpha, [Score=151, Expect=2e-42]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=149, Expect=6e-41]} {Smed: dd_Smed_v6_25116_0_1, dd_Smed_v6_25116_0_1, [Score=135, Expect=3e-36]} {RNA1509_44790} {RNA1310_18963} {RNA815_12996} Mlig455_052726 {REF} {Length: 2299} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=138.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=128.3]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [RH, Score=342, Expect=1e-113]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [RH, Score=340, Expect=8e-113]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [RH, Score=337, Expect=1e-111]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [RH, Score=341, Expect=4e-113]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [RH, Score=338, Expect=3e-112]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [RH, Score=335, Expect=2e-111]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [RH, Score=331, Expect=1e-109]} {Dmel: FBgn0024963, GluClalpha, [RH, Score=296, Expect=6e-96]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=281, Expect=2e-89]} {Smed: dd_Smed_v6_14666_0_1, dd_Smed_v6_14666_0_1, [Score=251, Expect=5e-79]} {RNA1509_44790} {RNA1310_18963} {RNA815_26083} |
56. | MligTC455_42510 | 125 | 2.6 | Mlig455_025998, Mlig455_070424 | Neo: - |
3.435 | - | - | 0.963 | 0.731 | 0.978 | 0.763 | Mlig455_025998 {REF} {Length: 1369} {RNA1310_73875.1} Mlig455_070424 {REF} {Length: 1082} {RNA1310_73875.1} |
|
57. | MligTC455_46395 | 870 | 18.13 | Mlig455_069471 | Neo: - Age: logFC(26M/2M)=0.458 |
PKD2 | 3.435 | - | - | 0.868 | 0.973 | 0.866 | 0.728 | Mlig455_069471 {REF} {Length: 3122} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.8]; Ion transport protein [PF00520.33, score=93.3]; EF hand [PF00036.34, score=32.7]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=753, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=750, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=1e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=387, Expect=8e-123]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=769, Expect=0.0]} {RNA1509_13522} {RNA1310_21296.2} {RNA815_3158.1} |
58. | MligTC455_42466 | 167 | 3.48 | Mlig455_031214 | Neo: - Age: logFC(26M/2M)=-0.318 Region-enriched R2: 3.417/0.02491 |
3.431 | - | - | 0.865 | 0.953 | 0.799 | 0.814 | Mlig455_031214 {REF} {Length: 2707} {RNA1509_33423} {RNA1310_11454.1, RNA1509_33423} {RNA1509_33423, RNA815_35037} | |
59. | MligTC455_40610 | 165 | 3.43 | Mlig455_064484 | Neo: - Age: - Region-enriched R2: 5.617/0.00105 |
3.423 | - | - | 0.978 | 0.965 | 0.711 | 0.769 | Mlig455_064484 {REF} {Length: 2931} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=24.9]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=154, Expect=2e-40]} {RNA1509_26568} {RNA1310_9342.1, RNA1509_26568} {RNA1509_26568, RNA815_7018} | |
60. | MligTC455_47412 | 245 | 5.11 | Mlig455_025659 | Neo: - |
RTL1 | 3.422 | - | - | 0.887 | 0.850 | 0.954 | 0.731 | Mlig455_025659 {REF} {Length: 3817} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=105.5]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=100.5]; Integrase zinc binding domain [PF17921.3, score=62.6]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=62.3]; Integrase core domain [PF00665.28, score=43.8]; Zinc knuckle [PF00098.25, score=21.5]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=91.7, Expect=6e-18]} {Mouse: ENSMUSG00000075592, Nynrin, NYN domain and retroviral integrase containing, [Score=63.9, Expect=1e-09]} {Smed: dd_Smed_v6_6563_0_1, dd_Smed_v6_6563_0_1, [Score=291, Expect=3e-82]} {RNA1509_33291} {RNA1310_923.1} {RNA815_1595} |
61. | MligTC455_14716 | 29 | 0.61 | Mlig455_043633 | Neo: - Age: - |
ANGPTL2 | 3.41 | - | - | 0.994 | 0.862 | 0.804 | 0.750 | Mlig455_043633 {REF} {Length: 1106} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=157.6]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=134, Expect=2e-35]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=133, Expect=4e-35]; ENSG00000085265, FCN1, ficolin 1, [Score=132, Expect=8e-36]; ENSG00000160339, FCN2, ficolin 2, [Score=128, Expect=4e-35]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=137, Expect=1e-36]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=134, Expect=1e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=131, Expect=1e-34]} {Dmel: FBgn0034160, CG5550, [Score=119, Expect=6e-32]} {Celegans: WBGene00017013, ensh-1, [Score=57.8, Expect=2e-09]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=114, Expect=1e-28]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3} |
62. | MligTC455_23640 | 29 | 0.6 | Mlig455_067288 | Neo: - Age: - |
3.409 | - | - | 0.806 | 0.922 | 0.980 | 0.701 | Mlig455_067288 {REF} {Length: 820} {RNA1310_58177} {RNA815_30723} | |
63. | MligTC455_13878 | 438 | 9.12 | Mlig455_008227 | Neo: - Age: logFC(26M/2M)=-0.747 |
3.401 | - | - | 0.810 | 0.922 | 0.958 | 0.711 | Mlig455_008227 {REF} {Length: 1960} {Pfam: Sperm-tail PG-rich repeat [PF07004.14, score=22.0]} {Mouse: ENSMUSG00000036557, Stpg4, sperm tail PG rich repeat containing 4, [RH, Score=87.8, Expect=2e-20]} {RNA1509_18072, RNA1509_22020, RNA1509_41492} {RNA1310_16702.1, RNA1509_18072, RNA1509_22020} {RNA1509_18072, RNA1509_22020, RNA815_7507.1} | |
64. | MligTC455_47094 | 240 | 5.01 | Mlig455_014204 | Neo: - Age: logFC(26M/2M)=-0.357 |
3.398 | - | - | 0.915 | 0.981 | 0.757 | 0.745 | Mlig455_014204 {REF} {Length: 3346} {Smed: dd_Smed_v6_4351_0_1, dd_Smed_v6_4351_0_1, [RH, Score=238, Expect=1e-74]} {RNA1509_35661} {RNA1310_8437, RNA1509_35661} {RNA1509_35661, RNA815_15552} | |
65. | MligTC455_43452 | 29 | 0.6 | Mlig455_013155 | Neo: - Age: - |
3.396 | - | - | 0.964 | 0.806 | 0.859 | 0.767 | Mlig455_013155 {REF} {Length: 920} {Pfam: Lectin C-type domain [PF00059.23, score=25.4]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=57.0, Expect=8e-10]} {RNA1509_20946} {RNA1310_57972} {RNA815_4785.4} | |
66. | MligTC455_41339 | 61 | 1.27 | Mlig455_021120 | Neo: - Age: - |
3.392 | - | - | 0.966 | 0.875 | 0.785 | 0.766 | Mlig455_021120 {REF} {Length: 294} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_118897} {RNA815_62550} | |
67. | MligTC455_20142 | 488 | 10.17 | Mlig455_036513 | Neo: - |
3.389 | - | - | 0.762 | 0.964 | 0.924 | 0.739 | Mlig455_036513 {REF} {Length: 1074} {NoTransDecoderORF} {RNA1509_4350} {RNA1310_20554, RNA1509_4350} {RNA1509_4350, RNA815_8810.1} | |
68. | MligTC455_16416 | 290 | 6.04 | Mlig455_000468 | Neo: - Age: - Region-enriched R2: 2.225/0.04782 |
ROR1 | 3.378 | - | - | 0.886 | 0.963 | 0.806 | 0.723 | Mlig455_000468 {REF} {Length: 2686} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=208.1]; Protein kinase domain [PF00069.27, score=77.3]; Kringle domain [PF00051.20, score=19.4]} {Human: ENSG00000185483, ROR1, receptor tyrosine kinase like orphan receptor 1, [Score=300, Expect=1e-89]} {Mouse: ENSMUSG00000035305, Ror1, receptor tyrosine kinase-like orphan receptor 1, [Score=295, Expect=2e-87]; ENSMUSG00000021464, Ror2, receptor tyrosine kinase-like orphan receptor 2, [Score=281, Expect=2e-82]} {Dmel: FBgn0010407, Ror, [Score=259, Expect=2e-76]} {Celegans: WBGene00000289, cam-1, Tyrosine-protein kinase receptor cam-1, [Score=217, Expect=2e-60]} {Smed: dd_Smed_v6_7911_0_1, dd_Smed_v6_7911_0_1, [Score=328, Expect=1e-100]} {RNA1509_35395} {RNA1310_13558} {RNA815_27446} |
69. | MligTC455_39047 | 39 | 0.81 | Mlig455_037921, Mlig455_038983 | Neo: - Age: - |
TNN | 3.375 | - | - | 0.864 | 0.798 | 0.953 | 0.760 | Mlig455_037921 {REF} {Length: 4077} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=111.9]} {Human: ENSG00000120332, TNN, tenascin N, [Score=95.5, Expect=1e-21]} {Mouse: ENSMUSG00000026725, Tnn, tenascin N, [Score=94.7, Expect=2e-21]} {Dmel: FBgn0050280, CG30280, [Score=87.0, Expect=3e-20]} {Celegans: WBGene00020516, T15B7.1, [Score=52.0, Expect=2e-07]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=73.6, Expect=1e-14]} {RNA1509_16377} {RNA1310_5710.1} {RNA815_14744.1} Mlig455_038983 {REF} {Length: 2023} {RNA1310_108685} {RNA815_54007} |
70. | MligTC455_24753 | 11 | 0.23 | Mlig455_016700 | Neo: - Age: - |
3.359 | - | - | 0.958 | 0.912 | 0.770 | 0.719 | Mlig455_016700 {REF} {Length: 1032} {Pfam: PAN domain [PF00024.28, score=20.1]} {RNA1310_36328.1} {RNA815_39270} | |
71. | MligTC455_46394 | 8810 | 183.54 | Mlig455_054818, Mlig455_054826 | Neo: - Age: - Region-specific R2: 1.771 Region-enriched R2: 1.255/0.00038 |
PKD2 | 3.358 | - | - | 0.848 | 0.962 | 0.774 | 0.774 | Mlig455_054818 {REF} {Length: 2992} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.7]; Ion transport protein [PF00520.33, score=93.3]; EF hand [PF00036.34, score=32.7]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=750, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=747, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=1e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=380, Expect=6e-120]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [Score=733, Expect=0.0]} {RNA1509_1615} {RNA1310_21296.2, RNA1509_1615} {RNA1509_1615, RNA815_3158.1} Mlig455_054826 {REF} {Length: 3118} {TRANSSPLICED} {Pfam: Polycystin cation channel [PF08016.14, score=487.7]; Ion transport protein [PF00520.33, score=93.4]; EF hand [PF00036.34, score=32.6]; Ferredoxin I 4Fe-4S cluster domain [PF18109.3, score=21.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=754, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=751, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=323, Expect=2e-96]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=387, Expect=1e-122]} {Smed: dd_Smed_v6_13327_0_1, dd_Smed_v6_13327_0_1, [RH, Score=769, Expect=0.0]} {RNA1509_13522} {RNA1310_21296.2} {RNA815_3158.1} |
72. | MligTC455_20443 | 430 | 8.96 | Mlig455_010917, Mlig455_033173 | Neo: - Age: - Region-specific R2: 4.126 Region-enriched R2: 3.438/0.00019 |
CFAP77 | 3.356 | - | - | 0.953 | 0.744 | 0.909 | 0.750 | Mlig455_010917 {REF} {Length: 1338} {Pfam: Domain of unknown function (DUF4483) [PF14825.8, score=38.6]} {Human: ENSG00000188523, CFAP77, cilia and flagella associated protein 77, [Score=47.8, Expect=3e-06]} {Mouse: ENSMUSG00000079502, Cfap77, cilia and flagella associated protein 77, [Score=50.1, Expect=4e-07]} {Smed: dd_Smed_v6_5179_0_1, dd_Smed_v6_5179_0_1, [Score=84.3, Expect=4e-20]} {RNA1509_46220} {RNA1310_36457, RNA1509_46220} {RNA1509_46220, RNA815_17196} Mlig455_033173 {REF} {Length: 978} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF4483) [PF14825.8, score=19.5]} {RNA1509_46220} {RNA1310_36457} {RNA815_17196} |
73. | MligTC455_17412 | 44 | 0.91 | Mlig455_069737 | Neo: - Age: - Region-enriched R2: 5.062/0.00923 |
3.349 | - | - | 0.750 | 0.885 | 0.981 | 0.733 | Mlig455_069737 {REF} {Length: 1628} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=42.8]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=72.8, Expect=3e-14]} {RNA1310_45758} {RNA815_42912} | |
74. | MligTC455_16096 | 69 | 1.44 | Mlig455_059809 | Neo: - Age: - |
ANGPTL1 | 3.341 | - | - | 0.748 | 0.974 | 0.859 | 0.760 | Mlig455_059809 {REF} {Length: 1391} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=117.9]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=109, Expect=1e-26]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=106, Expect=2e-25]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=110, Expect=3e-27]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=105, Expect=2e-25]} {Dmel: FBgn0003326, sca, scabrous, [Score=91.3, Expect=3e-20]} {Celegans: WBGene00017013, ensh-1, [Score=61.2, Expect=1e-10]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=77.8, Expect=5e-16]} {RNA1509_28467} {RNA1310_47262} {RNA815_18070.1} |
75. | MligTC455_14715 | 31 | 0.65 | Mlig455_043609 | Neo: - Age: - |
ANGPTL1 | 3.332 | - | - | 0.985 | 0.868 | 0.729 | 0.750 | Mlig455_043609 {REF} {Length: 1252} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=154.2]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=131, Expect=2e-34]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=128, Expect=2e-33]; ENSG00000085265, FCN1, ficolin 1, [Score=128, Expect=2e-34]; ENSG00000160339, FCN2, ficolin 2, [Score=125, Expect=5e-34]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=134, Expect=1e-35]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=129, Expect=7e-34]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=128, Expect=2e-33]} {Dmel: FBgn0033312, CG8642, [RH, Score=122, Expect=1e-31]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=112, Expect=7e-28]} {RNA1509_26827} {RNA1310_31596.2} {RNA815_17173.3} |
76. | MligTC455_24536 | 120 | 2.5 | Mlig455_028895 | Neo: - Age: Up-Down-Down |
TRPA1 | 3.287 | - | - | 0.744 | 0.978 | 0.860 | 0.705 | Mlig455_028895 {REF} {Length: 4399} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=276.9]; Ankyrin repeats (many copies) [PF13637.8, score=235.5]; Ankyrin repeats (many copies) [PF13857.8, score=187.3]; Ankyrin repeat [PF00023.32, score=185.3]; Ankyrin repeat [PF13606.8, score=184.2]; Ion transport protein [PF00520.33, score=31.3]} {Human: ENSG00000104321, TRPA1, transient receptor potential cation channel subfamily A member 1, [Score=295, Expect=6e-83]} {Mouse: ENSMUSG00000032769, Trpa1, transient receptor potential cation channel, subfamily A, member 1, [Score=277, Expect=4e-77]} {Dmel: FBgn0035934, TrpA1, Transient receptor potential cation channel A1, [Score=305, Expect=2e-86]} {Celegans: WBGene00007801, trpa-1, Transient receptor potential cation channel subfamily A member 1 homolog, [Score=276, Expect=1e-76]} {Smed: dd_Smed_v6_20683_0_1, dd_Smed_v6_20683_0_1, [RH, Score=551, Expect=2e-178]} {RNA1509_56559} {RNA1310_3837.1} {RNA815_4441} |
77. | MligTC455_15492 | 69 | 1.44 | Mlig455_022488 | Neo: - Age: Down-Up-Up |
3.26 | - | - | 0.762 | 0.971 | 0.768 | 0.759 | Mlig455_022488 {REF} {Length: 1351} {RNA1310_26051} {RNA815_10966} | |
78. | MligTC455_16749 | 454 | 9.45 | Mlig455_001550, Mlig455_046548 | Neo: - Age: logFC(26M/2M)=0.515 Region-specific R2: 4.360 Region-enriched R2: 3.409/0.00015 |
TRAF4 | 3.217 | - | - | 0.969 | 0.717 | 0.786 | 0.745 | Mlig455_001550 {REF} {Length: 4563} {Pfam: TRAF-type zinc finger [PF02176.20, score=81.2]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=27.3]; Seven in absentia protein family [PF03145.18, score=27.2]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=23.0]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=22.9]; zinc finger of C3HC4-type, RING [PF15227.8, score=20.4]; zf-RING of BARD1-type protein [PF14835.8, score=20.3]; Ring finger domain [PF13639.8, score=19.5]} {Human: ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=237, Expect=4e-72]} {Mouse: ENSMUSG00000017386, Traf4, TNF receptor associated factor 4, [Score=241, Expect=7e-74]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=164, Expect=1e-44]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [RH, Score=276, Expect=1e-87]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_20900} {RNA1310_14813, RNA1509_20900} {RNA1509_20900, RNA815_2335.1} Mlig455_046548 {REF} {Length: 3881} {Pfam: TRAF-type zinc finger [PF02176.20, score=81.2]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=27.3]; Seven in absentia protein family [PF03145.18, score=27.2]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=23.0]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=22.9]; zinc finger of C3HC4-type, RING [PF15227.8, score=20.4]; zf-RING of BARD1-type protein [PF14835.8, score=20.3]; Ring finger domain [PF13639.8, score=19.5]} {Human: ENSG00000076604, TRAF4, TNF receptor associated factor 4, [Score=236, Expect=1e-71]} {Mouse: ENSMUSG00000017386, Traf4, TNF receptor associated factor 4, [Score=240, Expect=3e-73]} {Dmel: FBgn0026319, Traf4, TNF-receptor-associated factor 4, [Score=164, Expect=9e-45]} {Celegans: WBGene00006612, trf-1, TNF Receptor Associated Factor (TRAF) homolog; TRF-1, [RH, Score=275, Expect=6e-87]} {Smed: dd_Smed_v6_13517_0_1, dd_Smed_v6_13517_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_20900} {RNA1310_14813} {RNA815_2335.1} |
79. | MligTC455_51536 | 78 | 1.62 | Mlig455_040699 | Neo: - Age: - |
2.912 | - | - | 0.954 | 0.984 | - | 0.974 | Mlig455_040699 {REF} {Length: 2015} {RNA1310_34295.1} {RNA815_22630} | |
80. | MligTC455_32311 | 54 | 1.12 | Mlig455_026929 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.612 Region-enriched R2: 7.331/0.00256 |
2.872 | - | - | 0.974 | - | 0.996 | 0.902 | Mlig455_026929 {REF} {Length: 1796} {Pfam: PAN domain [PF00024.28, score=22.2]} {RNA1310_30037.1} {RNA815_37290} | |
81. | MligTC455_40751 | 206 | 4.29 | Mlig455_045754 | Neo: - Age: Down-Up-Down |
2.867 | - | - | 0.940 | 0.949 | 0.978 | - | Mlig455_045754 {REF} {Length: 1094} {Pfam: Lectin C-type domain [PF00059.23, score=30.3]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=55.1, Expect=4e-09]} {RNA1310_36556.1} {RNA815_16968} | |
82. | MligTC455_29030 | 141 | 2.93 | Mlig455_061986 | Neo: - Age: logFC(26M/2M)=-0.349 Region-enriched R2: 5.117/0.03372 |
FZD5 | 2.841 | - | - | - | 0.959 | 0.986 | 0.896 | Mlig455_061986 {REF} {Length: 3701} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=386.1]; Fz domain [PF01392.24, score=95.9]} {Human: ENSG00000163251, FZD5, frizzled class receptor 5, [Score=582, Expect=0.0]} {Mouse: ENSMUSG00000045005, Fzd5, frizzled class receptor 5, [RH, Score=586, Expect=0.0]} {Dmel: FBgn0016797, fz2, frizzled 2, [Score=545, Expect=0.0]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=388, Expect=7e-127]} {Smed: dd_Smed_v6_16571_0_1, dd_Smed_v6_16571_0_1, [RH, Score=556, Expect=0.0]} {RNA1509_35313} {RNA1310_9623.1} {RNA815_2562.1} |
83. | MligTC455_47874 | 67 | 1.4 | Mlig455_000340 | Neo: - Age: - |
2.838 | - | - | 0.927 | 0.960 | 0.951 | - | Mlig455_000340 {REF} {Length: 1412} {Smed: dd_Smed_v6_3944_0_1, dd_Smed_v6_3944_0_1, [Score=97.4, Expect=9e-26]} {RNA1509_55952} {RNA1310_12426} {RNA815_33214} | |
84. | MligTC455_27650 | 178 | 3.72 | Mlig455_017720 | Neo: - Age: logFC(26M/2M)=-0.928 Region-enriched R2: 3.586/0.00082 |
ADAM33 | 2.837 | - | - | 0.929 | 0.920 | 0.988 | - | Mlig455_017720 {REF} {Length: 4499} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=124.3]; Disintegrin [PF00200.25, score=66.8]; Metallo-peptidase family M12 [PF13688.8, score=62.2]; ADAM cysteine-rich [PF08516.14, score=61.3]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=33.1]} {Human: ENSG00000149451, ADAM33, ADAM metallopeptidase domain 33, [Score=237, Expect=1e-64]; ENSG00000151651, ADAM8, ADAM metallopeptidase domain 8, [Score=233, Expect=2e-63]; ENSG00000168615, ADAM9, ADAM metallopeptidase domain 9, [Score=230, Expect=2e-62]; ENSG00000148848, ADAM12, ADAM metallopeptidase domain 12, [Score=228, Expect=4e-61]; ENSG00000069206, ADAM7, ADAM metallopeptidase domain 7, [Score=226, Expect=4e-61]; ENSG00000042980, ADAM28, ADAM metallopeptidase domain 28, [Score=226, Expect=4e-61]} {Mouse: ENSMUSG00000079058, Adam34, a disintegrin and metallopeptidase domain 34, [RH, Score=248, Expect=4e-69]; ENSMUSG00000050190, Gm5346, predicted gene 5346, [RH, Score=239, Expect=3e-66]} {Dmel: FBgn0265140, Meltrin, [RH, Score=288, Expect=1e-79]} {Celegans: WBGene00000074, adm-2, ADAM (Disintegrin plus metalloprotease) family, [Score=246, Expect=3e-67]} {Smed: dd_Smed_v6_5143_0_1, dd_Smed_v6_5143_0_1, [Score=225, Expect=3e-60]} {RNA1509_7654} {RNA1310_9319.1} {RNA815_4173.1} |
85. | MligTC455_19322 | 47 | 0.98 | Mlig455_060292 | Neo: - Age: - Region-enriched R5: 4.828/0.04092 |
2.836 | - | - | 0.914 | - | 0.985 | 0.937 | Mlig455_060292 {REF} {Length: 1265} {RNA1310_61465} {RNA815_19768} | |
86. | MligTC455_26999 | 330 | 6.88 | Mlig455_037719, Mlig455_037789 | Neo: - Age: - |
RBM12B | 2.832 | - | - | - | 0.965 | 0.890 | 0.977 | Mlig455_037719 {REF} {Length: 3624} {Pfam: Mitochondrial distribution and morphology protein 10 [PF12519.10, score=19.6]} {Human: ENSG00000183808, RBM12B, RNA binding motif protein 12B, [Score=58.9, Expect=4e-08]} {RNA1509_40809} {RNA1310_8203} {RNA815_13132} Mlig455_037789 {REF} {Length: 3262} {Human: ENSG00000183808, RBM12B, RNA binding motif protein 12B, [Score=61.2, Expect=7e-09]} {RNA1310_8203} {RNA815_13132} |
87. | MligTC455_40152 | 71 | 1.48 | Mlig455_044652 | Neo: - Age: - |
CALML3 | 2.832 | - | - | - | 0.920 | 0.944 | 0.968 | Mlig455_044652 {REF} {Length: 973} {Pfam: EF hand [PF00036.34, score=85.2]; EF-hand domain pair [PF13499.8, score=84.3]; EF-hand domain [PF13405.8, score=70.9]; EF-hand domain pair [PF13833.8, score=61.0]; EF hand [PF13202.8, score=51.9]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=36.6]; EF-hand domain [PF14658.8, score=21.5]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=94.0, Expect=2e-24]} {Mouse: ENSMUSG00000033765, Calm4, calmodulin 4, [Score=86.3, Expect=1e-21]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=76.3, Expect=7e-18]} {Celegans: WBGene00006583, tnc-2, Troponin C, isoform 2, [Score=63.5, Expect=4e-13]} {Smed: dd_Smed_v6_11942_0_1, dd_Smed_v6_11942_0_1, [Score=96.3, Expect=1e-25]} {RNA1310_41156} {RNA815_20058} |
88. | MligTC455_34484 | 68 | 1.41 | Mlig455_026268 | Neo: - Age: Up-Down-Down Region-enriched R4: 4.168/0.01366 |
GLRA3 | 2.824 | - | - | 0.878 | 0.986 | - | 0.960 | Mlig455_026268 {REF} {Length: 2412} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=153.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=129.9]} {Human: ENSG00000145451, GLRA3, glycine receptor alpha 3, [RH, Score=345, Expect=2e-113]; ENSG00000101958, GLRA2, glycine receptor alpha 2, [RH, Score=342, Expect=2e-112]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [RH, Score=340, Expect=7e-112]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [RH, Score=341, Expect=3e-112]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [RH, Score=340, Expect=5e-112]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [RH, Score=339, Expect=1e-111]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [RH, Score=332, Expect=4e-109]} {Dmel: FBgn0024963, GluClalpha, [RH, Score=301, Expect=7e-97]} {Celegans: WBGene00001512, gab-1, Gamma-aminobutyric acid receptor subunit beta, [Score=279, Expect=2e-87]} {Smed: dd_Smed_v6_14666_0_1, dd_Smed_v6_14666_0_1, [Score=257, Expect=1e-80]} {RNA1509_44790} {RNA1310_18963} {RNA815_12996} |
89. | MligTC455_29168 | 95 | 1.99 | Mlig455_001005 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.838/0.04040 |
DNAH5 | 2.81 | - | - | 0.880 | 0.956 | - | 0.974 | Mlig455_001005 {REF} {Length: 14882} {Pfam: Dynein heavy chain, N-terminal region 1 [PF08385.14, score=578.4]; Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=466.5]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=431.3]; Dynein heavy chain C-terminal domain [PF18199.3, score=314.7]; P-loop containing dynein motor region D4 [PF12780.9, score=302.4]; ATP-binding dynein motor region [PF12781.9, score=290.8]; P-loop containing dynein motor region [PF12775.9, score=229.7]; Dynein heavy chain AAA lid domain [PF18198.3, score=179.1]; Microtubule-binding stalk of dynein motor [PF12777.9, score=143.2]; Dynein heavy chain region D6 P-loop domain [PF03028.17, score=121.5]; AAA domain (dynein-related subfamily) [PF07728.16, score=75.6]; Dynein heavy chain AAA lid domain [PF17852.3, score=70.7]; AAA+ lid domain [PF17857.3, score=60.9]; AAA ATPase domain [PF13191.8, score=22.0]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=21.4]; P-loop containing region of AAA domain [PF13555.8, score=20.3]} {Human: ENSG00000039139, DNAH5, dynein axonemal heavy chain 5, [RH, Score=6260, Expect=0.0]} {Mouse: ENSMUSG00000022262, Dnah5, dynein, axonemal, heavy chain 5, [RH, Score=6234, Expect=0.0]} {Dmel: FBgn0037726, CG9492, [RH, Score=5093, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=1290, Expect=0.0]} {Smed: dd_Smed_v6_4569_0_1, dd_Smed_v6_4569_0_1, [RH, Score=6941, Expect=0.0]} {RNA1509_51275} {RNA1310_408, RNA1509_51275} {RNA1509_51275, RNA815_44.1} |
90. | MligTC455_13095 | 40 | 0.82 | Mlig455_036239 | Neo: - Age: - |
2.809 | - | - | 0.867 | 0.961 | 0.981 | - | Mlig455_036239 {REF} {Length: 2786} {RNA1509_41201} {RNA1310_51044} {RNA815_51130} | |
91. | MligTC455_15662 | 187 | 3.89 | Mlig455_030386 | Neo: - Age: - Region-enriched R2: 3.832/0.01388 Regeneration-upregulated BL: 4.705 Regeneration-enriched BL: 4.705 |
NR2E1 | 2.805 | - | - | - | 0.865 | 0.948 | 0.992 | Mlig455_030386 {REF} {Length: 2439} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=98.4]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=73.9]} {Human: ENSG00000112333, NR2E1, nuclear receptor subfamily 2 group E member 1, [RH, Score=190, Expect=8e-54]} {Mouse: ENSMUSG00000019803, Nr2e1, nuclear receptor subfamily 2, group E, member 1, [Score=190, Expect=2e-54]} {Dmel: FBgn0003720, tll, tailless, [RH, Score=205, Expect=3e-59]} {Celegans: WBGene00003657, nhr-67, Nuclear hormone receptor family member nhr-67, [RH, Score=194, Expect=1e-55]} {Smed: dd_Smed_v6_21347_0_1, dd_Smed_v6_21347_0_1, [RH, Score=189, Expect=4e-54]} {RNA1509_39776} {RNA1310_21550} {RNA815_27099.1} |
92. | MligTC455_25463 | 163 | 3.39 | Mlig455_001181 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.027 Region-enriched R2: 4.234/0.00772 |
2.798 | - | - | - | 0.942 | 0.968 | 0.888 | Mlig455_001181 {REF} {Length: 1504} {RNA1509_58508} {RNA1310_32754} {RNA815_47065} | |
93. | MligTC455_40352 | 49 | 1.03 | Mlig455_024410 | Neo: - Age: - |
2.797 | - | - | 0.884 | 0.937 | 0.976 | - | Mlig455_024410 {REF} {Length: 1509} {TRANSSPLICED} {RNA1310_29008} {RNA815_41596} | |
94. | MligTC455_16952 | 79 | 1.65 | Mlig455_001182 | Neo: - Age: - |
2.789 | - | - | 0.931 | 0.967 | 0.891 | - | Mlig455_001182 {REF} {Length: 3873} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [RH, Score=67.0, Expect=3e-14]} {RNA1509_4618} {RNA1310_46281} {RNA815_28578} | |
95. | MligTC455_50764 | 284 | 5.92 | Mlig455_049612 | Neo: - Age: - |
PAQR6 | 2.785 | - | - | - | 0.973 | 0.931 | 0.881 | Mlig455_049612 {REF} {Length: 2285} {TRANSSPLICED} {Pfam: Haemolysin-III related [PF03006.22, score=137.4]} {Human: ENSG00000160781, PAQR6, progestin and adipoQ receptor family member 6, [RH, Score=169, Expect=1e-49]; ENSG00000137819, PAQR5, progestin and adipoQ receptor family member 5, [RH, Score=167, Expect=7e-49]} {Mouse: ENSMUSG00000032278, Paqr5, progestin and adipoQ receptor family member V, [RH, Score=171, Expect=3e-50]; ENSMUSG00000041423, Paqr6, progestin and adipoQ receptor family member VI, [RH, Score=166, Expect=3e-48]} {Dmel: FBgn0038256, CG7530, [Score=65.5, Expect=1e-11]} {Celegans: WBGene00019643, K11C4.2, [RH, Score=97.1, Expect=5e-23]} {Smed: dd_Smed_v6_14141_0_1, dd_Smed_v6_14141_0_1, [RH, Score=187, Expect=1e-56]} {RNA1509_43309} {RNA1310_31297} {RNA815_20550} |
96. | MligTC455_51228 | 99 | 2.07 | Mlig455_021448 | Neo: - Age: - |
ANK2 | 2.779 | - | - | 0.913 | 0.886 | - | 0.980 | Mlig455_021448 {REF} {Length: 6454} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=535.9]; Ankyrin repeat [PF00023.32, score=442.4]; Ankyrin repeats (many copies) [PF13637.8, score=435.7]; Ankyrin repeat [PF13606.8, score=370.1]; Ankyrin repeats (many copies) [PF13857.8, score=364.9]; Ion transport protein [PF00520.33, score=37.4]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=325, Expect=3e-89]; ENSG00000151150, ANK3, ankyrin 3, [Score=323, Expect=2e-88]; ENSG00000029534, ANK1, ankyrin 1, [Score=312, Expect=3e-85]} {Mouse: ENSMUSG00000069601, Ank3, ankyrin 3, epithelial, [Score=352, Expect=2e-97]} {Dmel: FBgn0016920, nompC, no mechanoreceptor potential C, [RH, Score=1339, Expect=0.0]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [RH, Score=1296, Expect=0.0]} {Smed: dd_Smed_v6_21003_0_1, dd_Smed_v6_21003_0_1, [RH, Score=1614, Expect=0.0]} {RNA1509_34114} {RNA1310_1922} {RNA815_29851} |
97. | MligTC455_54337 | 46 | 0.96 | Mlig455_000362 | Neo: - |
PKDREJ | 2.779 | - | - | 0.982 | 0.858 | 0.939 | - | Mlig455_000362 {REF} {Length: 11405} {Pfam: Polycystin cation channel [PF08016.14, score=291.7]; PLAT/LH2 domain [PF01477.25, score=67.3]; Ion transport protein [PF00520.33, score=42.2]; GPCR proteolysis site, GPS, motif [PF01825.23, score=27.7]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=274, Expect=2e-73]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=306, Expect=2e-83]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=152, Expect=6e-37]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=291, Expect=4e-79]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=1425, Expect=0.0]} {RNA1509_16432} {RNA1310_1236, RNA1509_16432} {RNA1509_16432, RNA815_2411} |
98. | MligTC455_21580 | 101 | 2.11 | Mlig455_032452 | Neo: - Age: - |
WSCD2 | 2.776 | - | - | 0.847 | 0.943 | 0.986 | - | Mlig455_032452 {REF} {Length: 945} {Pfam: WSC domain [PF01822.21, score=57.3]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.0, Expect=3e-07]; ENSG00000179314, WSCD1, WSC domain containing 1, [Score=51.2, Expect=6e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=53.1, Expect=9e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=52.8, Expect=9e-08]} {RNA1310_78298} {RNA815_49767} |
99. | MligTC455_40851 | 132 | 2.76 | Mlig455_042077 | Neo: - Age: logFC(26M/2M)=0.724 Region-enriched R2: 3.969/0.02676 |
PKD1L2 | 2.775 | - | - | - | 0.900 | 0.977 | 0.898 | Mlig455_042077 {REF} {Length: 4836} {Pfam: PLAT/LH2 domain [PF01477.25, score=68.6]; Polycystin cation channel [PF08016.14, score=53.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=220, Expect=3e-58]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=212, Expect=7e-56]} {Dmel: FBgn0050048, CG30048, [Score=55.8, Expect=2e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=122, Expect=1e-27]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=328, Expect=2e-94]} {RNA1509_8046} {RNA1310_93} {RNA815_1216} |
100. | MligTC455_42376 | 61 | 1.27 | Mlig455_069890 | Neo: - Age: - |
2.77 | - | - | 0.955 | 0.905 | 0.910 | - | Mlig455_069890 {REF} {Length: 630} {TRANSSPLICED} {Pfam: PAN domain [PF00024.28, score=26.1]} {RNA1509_53783} {RNA1310_37190} {RNA815_24434} |